FDA Announces Warning for Some Birth Control Pills

.

FDA Announces Warning for Some Birth Control Pills

As per recent reports, it has been revealed that FDA has asked the birth pill manufacturers to carry a warning if their drug carries the hormone drospirenone. The warning should contain the message that person taking the pill can develop fatal blood clots.

Some of the many birth control drugs, which will need to carry the warning, are Beyaz, Safyral, Yasmin, and Yaz and Gianvi, Loryna, Ocella and Zarah. The FDA said that the drugs, which carry the hormone, increase the risk of developing blood clots by three times. However, no such risk is present in other drugs, which do not carry the hormone drospirenone.

It has been found that changes in the labeling were proposed at an FDA advisory committee in December 2011, but it is now that the proposal has been passed. It is, however, recommended that women should consult their respective GPs before they start taking any birth control pill.

"Women who use birth control pills with drospirenone (like Yaz) may have a higher risk of getting a blood clot”, read the US Food and Drug Administration website.

Experts were of the view that drospirenone is nothing but a synthetic version of progesterone, a female sex hormone.


Latest News

Agreement between Amazon.com and Simon & Schuster to be Advantageous for Both th
Nadella gets a Pay Package Worth $84M from Microsoft; Announces Help in Ebola Re
Slowest Growth in China since the 2008/9 Global Crisis
New Models of iPhone Helps Apple to Achieve a Record Profit
Reheating pasta makes it healthier
Google Glass’ first addict
High-fat meals can cause obesity in men before women
Fujifilm shares go up after Ebola drug announcement
QEP Pipeline Assets Bought by Tesoro in a $2.5 Billion Deal
Adidas’s Reebok to Get a $2.2 billion Bid from Investors
Survey Reveals Slow Wage Increases in the U.S
Eurozone’s Low Performance Draw Mixed Reactions